small molecule

GASTROCROM

CROMOLYN SODIUM

Loss of exclusivity—loss of exclusivity
CompanyVIATRIS SPECIALITY LLC

Drug detail

Brand nameGASTROCROM
Active ingredientCROMOLYN SODIUM
Strength100MG/5ML
Dosage formCONCENTRATE
RouteORAL
ModalitySmall molecule
FDA approvalFebruary 1996
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.